Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05389501Not ApplicableUnknown

Intervention to Improve Social Policy for Maternal and Child Health

Role: lead

NCT04603079Not ApplicableCompleted

Nurse Leadership for Hospital Infection Control

Role: lead

NCT04603092Not ApplicableCompleted

Digital Health Literacy Intervention for Disadvantaged Women During Corona

Role: lead

NCT04346667Phase 4Terminated

Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds

Role: collaborator

All 4 trials loaded